Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
5.00
+0.07 (1.52%)
At close: Mar 6, 2026, 4:00 PM EST
5.26
+0.26 (5.10%)
After-hours: Mar 6, 2026, 6:49 PM EST
Molecular Partners AG Employees
Molecular Partners AG had 153 employees as of June 30, 2025. The number of employees decreased by 6 or -3.47% since the number was reported on December 31, 2024.
Employees
153
Change
-6
Growth
-3.47%
Revenue / Employee
n/a
Profits / Employee
-$493,725
Market Cap
187.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Editas Medicine | 246 |
| ProQR Therapeutics | 166 |
| Heron Therapeutics | 128 |
| Nkarta | 105 |
| Tenaya Therapeutics | 97 |
| Compugen | 74 |
| Cartesian Therapeutics | 66 |
| SAB Biotherapeutics | 63 |
MOLN News
- 9 days ago - Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript - Seeking Alpha
- 4 weeks ago - Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026 - GlobeNewsWire
- 7 weeks ago - Molecular Partners AG (MOLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting - GlobeNewsWire
- 4 months ago - Molecular Partners AG (MOLN) Discusses First Human Imaging Data and Clinical Plans for MP0712 Radiotherapy Program Transcript - Seeking Alpha
- 4 months ago - Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action - GlobeNewsWire